Clinical study on long-term overall survival of advanced non-small-cell lung cancer patients treated with Chinese medicine and western medicine

被引：0
|
作者：
Yan-zhi Chen
Xiao-bing Feng
Zhan-dong Li
Wen-xian Zheng
Hong Sun
Ping-ping Li
机构：
[1] Peking University Cancer Hospital & Institute,Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Integrated Traditional Chinese and Western Medicine
来源：
Chinese Journal of Integrative Medicine | 2014年 / 20卷
关键词：
non-small cell lung cancer; long-term overall survival; prognosis; Chinese medicine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：179 / 183
页数：4
相关论文
共 50 条
  • [31] A systems pathology model for predicting overall survival in patients with refractory, advanced non-small-cell lung cancer treated with gefitinib
    Donovan, Michael J.
    Kotsianti, Angeliki
    Bayer-Zubek, Valentina
    Verbel, David
    Teverovskiy, Mikhail
    Cordon-Cardo, Carlos
    Costa, Jose
    Greco, F. Anthony
    Hainsworth, John D.
    Parums, Dinah V.
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (08) : 1518 - 1526
  • [32] Long-term survival in patients with advanced melanoma, renal cell carcinoma, or non-small cell lung cancer treated with nivolumab
    Topalian, Suzanne L.
    Hodi, F. Stephen
    Brahmer, Julie R.
    Gettinger, Scott N.
    Smith, David C.
    McDermott, David F.
    Powderly, John D.
    Sosman, Jeffrey A.
    Atkins, Michael B.
    Spigel, David R.
    Antonia, Scott J.
    Drilon, Alexander
    Bhore, Rafia
    Hosein, Fareeda
    Sznol, Mario
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [33] Impact of prophylactic Cranial Irradiation on Overall Survival of Patients with advanced non-small-cell Lung Cancer
    Schmidt, Julia
    Appold, Steffen
    Troost, Esther G. C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (05) : 453 - 455
  • [34] Retrospective analysis of long-term survival factors in patients with advanced non-small cell lung cancer treated with nivolumab
    Murakami, Yusuke
    Tamiya, Akihiro
    Taniguchi, Yoshihiko
    Adachi, Yuichi
    Enomoto, Takatoshi
    Azuma, Koji
    Inagaki, Yuji
    Kouno, Shunichi
    Matsuda, Yoshinobu
    Okishio, Kyoichi
    Atagi, Shinji
    THORACIC CANCER, 2022, 13 (04) : 593 - 601
  • [35] Long-term survival of patients with advanced non-small cell lung cancer treated using immune checkpoint inhibitors
    Tamiya, Akihiro
    RESPIRATORY INVESTIGATION, 2024, 62 (01) : 85 - 89
  • [36] Traditional Chinese medicine as adjunctive therapy improves the long-term survival of lung cancer patients
    Yueh-Hsiang Liao
    Chia-Ing Li
    Cheng-Chieh Lin
    Jaung-Geng Lin
    Jen-Huai Chiang
    Tsai-Chung Li
    Journal of Cancer Research and Clinical Oncology, 2017, 143 : 2425 - 2435
  • [37] Gefitinib for Chinese patients with advanced non-small-cell lung cancer
    Xiaotong, Z
    Longyun, L
    Xinlin, MU
    LUNG CANCER, 2004, 45 : S79 - S79
  • [38] Chinese Medicine Treatment Prolonged Survival in Small Cell Lung Cancer Patients: A Clinical Observation
    XU Xiaoqing
    DENG Wenqi
    WANG Dayang
    LI Meng
    KOU Donglei
    ZHANG Peitong
    Chinese Journal of Integrative Medicine , 2021, (07) : 496 - 501
  • [39] Traditional Chinese medicine as adjunctive therapy improves the long-term survival of lung cancer patients
    Liao, Yueh-Hsiang
    Li, Chia-Ing
    Lin, Cheng-Chieh
    Lin, Jaung-Geng
    Chiang, Jen-Huai
    Li, Tsai-Chung
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (12) : 2425 - 2435
  • [40] Chinese Medicine Treatment Prolonged Survival in Small Cell Lung Cancer Patients: A Clinical Observation
    XU Xiao-qing
    DENG Wen-qi
    WANG Da-yang
    LI Meng
    KOU Dong-lei
    ZHANG Pei-tong
    Chinese Journal of Integrative Medicine, 2021, 27 (07) : 496 - 501
12345